Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib MSUS Assessment in RA
NCT02321930Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Feb 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tofacitinib oral solution in rheumatoid arthritis (RA), sponsored by University of California, Los Angeles. Started Feb 2016; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02321930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02321930.